Antiviral activity and mechanism of action of calanolide A against the human immunodeficiency virus type-1

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 2, 1996, Pages 645-651

  Currens, Michael J ^a   Gulakowski, Robert J ^a   Mariner, Jennifer M ^a   Moran, Robert A ^a   Buckheit Jr , Robert W ^a   Gustafson, Kirk R ^a   McMahon, James B ^a   Boyd, Michael R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ETHOXYMETHYL 5 ETHYL 6 PHENYLTHIO 2 THIOURACIL; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CALANOLIDE A; DNA DIRECTED DNA POLYMERASE ALPHA; FOSCARNET; NEVIRAPINE; NSC 313410; NSC 602670; NSC 606170; NSC 641530; NSC 648400; RNA DIRECTED DNA POLYMERASE INHIBITOR; THIOURACIL DERIVATIVE; UNCLASSIFIED DRUG; ZALCITABINE; ZIDOVUDINE; ZIDOVUDINE 5' TRIPHOSPHATE;

ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG MECHANISM; DRUG RESISTANCE; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; LIFE CYCLE; PRIORITY JOURNAL;

ANTI-HIV AGENTS; CELL LINE; COUMARINS; DNA-DIRECTED DNA POLYMERASE; HIV-1; HUMANS; PYRANOCOUMARINS; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0030439224     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. ARNOLD, E., JACOBO-MOLINA, A., NANN, R. G., WILLIAMS, R. L., LU, X., DING, J., CLARK, A. J., ZHANG, A., FERRIS, A. L. AND CLARK, P.: Structure of HIV-1 reverse transcriptase/DNA complex at 7 Å resolution showing active site locations. Nature 357: 85-89, 1992.
2. BALZARINI, J., KANG, G-J., DALAL, M., HERDIROJIN, P., DECLERCQ, E., BRODER, S. AND JOHNS, D. G.: Both 2′,3′-dideoxythymidine and its 2′,3′-unsaturated derivative (2′,3′0dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro. Biochem. Biophys. Res. Commun. 142: 128-134, 1987.
3. BIESERT, L., ZIMMERMANN, F., SCHRODER, B., MATTHES, E., SUHARTONO, H., DIETRICH, U. AND RUBSAMEN-WAIGMANN, H.: Biochemical and genetical analysis of AZT-resistant HIV-mutants. Behring Inst. Mitt. 89: 74-80, 1991.
4. BOYER, P. L., CURRENS, M. J., MCMAHON, J. B., BOYD, M. R. AND HUGHES, S. H.: Analysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptase. J. Virol. 67: 2412-2420, 1993.
5. BOYER, P. L., DING, J., ARNOLD, E. AND HUGHES, S. H.: Subunit specificity of mutations that confer resistance to nonnucleoside inhibitors in human immunodeficiency virus type 1 reverse transcriptase. Antimicrob. Agents Chemother. 38: 1909-1914, 1994.
6. BUCKHEIT, R. W. JR., FLIAKAS-BOLTZ, V., DECKER, W. D., ROBERSON, J. L., STUP, T. L., PYLE, C. A., WHITE, E. L., MCMAHON, J. B., CURRENS, M. J., BOYD, M. R., BADER, J. P.: Comparative anti-HIV evaluation of diverse HIV-1-specific reverse transcriptase inhibitor-resistant virus isolates demonstrates the existence of distinct phenotypic subgroups. Antiviral Res. 26: 117-132, 1995.
7. CHEN, Y.-C., BOHN, E. W., PLANCK, S. R. AND WILSON, S. H.: Mouse DNA polymerase α: Subunit structure and identification of a species with associated exonuclease. J. Biol. Chem. 254: 11678-11687, 1979.
8. CLARK, P. K., FERRIS, A. L., MILLER, D. A., HIZI, A., KIM, K. W., DERINGER, B. S., MELLINI, M. L., CLARK, A. J., ARNOLD, G. F., LEBHERZ, W., ARNOLD, E., MUSCHIK, G. M. AND HUGHES, S. H.: HIV-1 reverse transcriptase purified from a recombinant strain of Escherichia, coli. AIDS Res. Hum. Retroviruses 6: 753-764, 1990.
9. CLOYD, M. W. AND MOORE, B. E.: Spectrum of biological properties of human immune-deficiency virus (HIV-1) isolates. Virology 174: 103-116, 1990.
10. CURRENS, M. J., MARINER, J. M., MCMAHON, J. B. AND BOYD, M. R.: Kinetic analysis of inhibition of human immunodeficiency virus type-1 reverse transcriptase by calanolide A. J. Pharmacol. Exp. Ther. 279: 652-661, 1996.
11. DECLERCQ, E.: HIV resistance to reverse transcriptase inhibitors. Biochem. Pharm. 47: 155-169 1994.
12. FULLER, R. W., BOKESCH, H. R., GUSTAFSON, K. R., MCKEE, T. C., CARDELLINA, J. C. I. I., MCMAHON, J. B., CRAGG, G. M., SOEJARTO, D. D. AND BOYD, M. R.: HIV-inhibitory coumarins from the latex of the tropical rainforest tree Calophyllum teysmannii var. inophylloide. Bioorg. Med. Chem. Letts. 4: 1961-1964, 1994.
13. GULAKOWSKI, R. J., MCMAHON, J. B., STALEY, P. G., MORAN, R. A. AND BOYD, M. R.: A semi-automated multiparameter approach for anti-HIV drug screening. J. Virol. Methods 33: 87-100, 1991.
14. HIZI, A., MCGILL, C. AND HUGHES, S. H.: Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants. Proc. Natl. Acad. Sci. U.S.A. 85: 1218-1222, 1988.
15. HIZI, A., TAL, R., SHAHARABANY, M., CURRENS, M. J., BOYD, M. R., HUGHES, S. H. AND MCMAHON, J. B.: Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitors. Antimicrob. Agents Chemother. 37: 1037-1042, 1993.
16. HIZI, A., TAL, R., SHAHARABANY, M. AND LOYA, S.: Catalytic properties of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2. J. Biol. Chem. 266: 6230-6239, 1991.
17. KASHMAN, Y., GUSTAFSON, K. R., FULLER, R. W., CARDELLINA, J. H. I. I., MCMAHON, J. B., CURRENS, M. J., BUCKHEIT, R. W., JR., HUGHES, S. H., CRAGG, G. M. AND BOYD, M. R.: The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum [published erratum appears in J. Med. Chem. 1993 Apr 16; 36: 1110]. J. Med. Chem. 35: 2735-2743, 1992.
18. KOHLSTAEDT, L. A., WANG, J., FRIEDMAN, J. M., RICE, P. A. AND STEITZ, T. A.: Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256: 1783-1790, 1992.
19. LARDER, B. A., DARBY, G. AND RICHMAN, D. D.: HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 243: 1731-1734, 1989a.
20. LARDER, B. A., KEMP, S. D., DARBY, G. AND RICHMAN, D. D.: Variants of HIV resistant to zidovudine (AZT). Int. Conf. AIDS 5: 516, 1989b.
21. MCMAHON, J. B., GULAKOWSKI, R. J., WEISLOW, O. S., SCHULTZ, R. J., NARAYANAN, V. L., CLANTON, D. J., PEDEMONTE, R., WASSMUNDT, F. W., BUCKHEIT, JR., R. W., DECKER, W. D., WHITE, E. L., BADER, J. P. AND BOYD, M. R.: Diarylsulfones, a new chemical class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptase. Antimicrob. Agents Chemother. 37: 754-760, 1993.
22. MITSUYA, H., JARRETT, R. F., MATSUKURA, M., DI MARZO VERONESE, F., DEVICO, A. L., SARNGADHARAN, M. G., JOHNS, D. G., REITZ, M. S. AND BRODER, S.: Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T-cells protected by 2′,3′-dideoxynucleosides in vitro. Proc. Natl. Acad. Sci. U.S.A. 84: 2033-2037, 1987.
23. NARA, P. L., HATCH, W. C., DUNLOP, N. M., ROBEY, W. G., ARTHUR, L. O., GONDA, M. A. AND FISCHINGER, P. J.: Simple, rapid, quantitative syncytium forming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res. Hum. Retroviruses 3: 283-302, 1987.
24. NUNBERG, J. H., SCHLEIF, W. A., BOOTS, E. J., O'BRIEN, J. A., QUINTERO, J. C., HOFFMAN, J. M., EMINI, E. A. AND GOLDMAN, M. E.: Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors. J. Virol. 65: 4887-4892, 1991.
25. PRICHARD, M. N. AND SHIPMAN, C. J.: A three-dimensional model to analyze drug-drug interactions [published erratum appears in Antiviral Res. 1991 Feb;15(2):following 168] [see comments]. Antiviral Res. 14: 181-205, 1990.
26. RICHMAN, D. D., DARBY, G. AND LARDER, B. A.: Resistance to HIV drugs. Int. Conf. AIDS 5: TBO 16, 1989.
27. RIDDLER, S. A., ANDERSON, R. E. AND MELLORS, J. W.: Antiretroviral activity of stavudinc (2′,3′-didehydro-3′-deoxythymidine, D4T). Antiviral Res. 27: 198-203, 1995.
28. STEITZ, T. A., SMERDON, S. J., JAGER, J. AND JOYCE, C. M.: A unified polymerase mechanism for nonhomologous DNA and RNA polymerases. Science 266: 2022-2025, 1994.
29. TANTILLO, C., DING, J., JACOBO-MOLINA, A., NANNI, R. G., BOYER, P. L., HUGHES, S. H., PAUWELS, R., ANDRIES, K., JANSSEN, P. A. AND ARNOLD, E.: Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance. J. Mol. Biol. 243: 369-387, 1994.
30. WAINBERG, M. A., GAO, Q., YAO, X. J., PARNIAK, M. A., FANNING, M., MONTANER, J. S., O'SHAUGHNESSY, M., TSOUKAS, C. AND RUEDY, J.: Rapid generation of AZT-resistant strains of HIV-1 after low-dose therapy and by in vitro selection. Int. Conf. AIDS 7: 79, 1991.
31. WHITE, E. L., BUCKHEIT, R. W., ROSS, L. J., GERMANY, J. M., ANDRIES, K., PAUWELS, R., JANSSEN, P. A. J., SHANNON, W. M. AND CHIRIGOS, M. A.: A TIBO derivative, R82913, is a potent inhibitor of HIV-1 reverse transcriptase with heteropolymer templates. Antiviral Res. 16: 257-266, 1991.
32. YARCHOAN, R., MITSUTA, H., PLUDA, J., MARCZYK, K. S., THOMAS, R. V., HARTMAN, N. R., BROUWERS, P., PERNO, C.-F., ALLAIN, J.-P., JOHNS, D. G. AND BRODER, S.: The National Cancer Institute phase I study of ddI administration in adults with AIDS or AIDS-related complex: Analysis of activity and toxicity profiles. Rev. Infect. Dis. 12: 5522-5533, 1990.
33. YARCHOAN, R., PERNO, C. F., THOMAS, R. V., KLECKER, R. W., ALLAIN, J.-P., WILLS, R. J., MCATEE, N., FISCHL, M. A., DUBINSKY, R., MCNEELY, M. C., MITSUYA, H., PLUDA, J. M., LAWLEY, T. J., LEUTHER, M., SAFAI, B., COLLINS, J. M., MYERS, C. E. AND BRODER, S.: Phase I studies of 2′,3′-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT). Lancet 1: 76-81, 1988a.
34. YARCHOAN, R., PLUDA, J. M., PERNO, C. F., MITSUYA, H. AND BRODER, S.: Antiretroviral therapy of human immunodeficiency virus infection: current strategies and challenges for the future [published erratum appears in Blood 1991 Dec 15;78(12):3330]. Blood 78: 859-884, 1991.
35. YARCHOAN, R., THOMAS, R. V., GRAFMAN, J., WICHMAN, A., DALAKAS, M., MCATEE, N., BERG, G., FISCHL, M., PERNO, C. F., KLECKER, R. W., BUCHBINDER, A., TAY, S., LARSON, S. M., MYERS, C. E. AND BRODER, S.: Long-term administration of 3′-azido-2′,3′-dideoxythymidine to patients with AIDS-related neurological disease. Ann. Neurol. 23(Suppl): S82-S87, 1988b.
36. YARCHOAN, R., THOMAS, R. V., PLUDA, J. M., HARTMAN, N. R., MITSUYA, H., PERNO, C. F., MARCZYK, K., JOHNS, D. G. AND BRODER, S.: An initial study of 2′,3′-dideoxyinosine (ddI) in patients with AIDS or AIDS-related complex. Clin. Res. 37: 445A, 1989.